Human PSCs
PSC service description:
VGER can perform full-service human pluripotent stem cell genome editing projects on a collaborative basis. Projects require director pre-approval of project timeline, staff effort support, and supply fee for a period to be determined based on genome editing project complexity. We are happy to consult with you to discuss your project ideas.
PSC cell availability:
- H9
- WTC-11
- dCas9-KRAB
- Patient-derived (requires additional characterization prior to acceptance)
Types of projects available:
- Knockouts, point mutations, and short fusions, such as epitope tag, are produced using CRISPR RNPs and ssDNA delivered by electroporation
- Larger KIs up to 3 kb are produced using AAV6-packaged ssDNA donors and RNP electroporation.
- CRISPR interference iPSCs can be produced by delivery of sgRNA-expressing transposons by piggyBac transgenesis.
Why work with VGER instead of a company?
VGER provides you with any or all the clones produced for your project, not just 1-2. We can assist with grant preparation, manuscript preparation, and offer general advice to help you work with the PSCs we produce in your own lab.
Why work with VGER when you have plenty of hands in your own lab?
VGER staff are highly skilled in CRISPR editing design and can design highly efficient strategies with straightforward screening assays. High quality PSCs are necessary to produce healthy genome edited PSCs. Chromosomal mutations can occur in stressed cell cultures or may be present in the original patient cell line. VGER has dedicated cell culture rooms for PSC editing so there is no fear of contamination and staff are highly skilled at culture.
Quality control
PSCs are cultured using StemCell Technologies TeSR media and reagents. We visually inspect PSC colony morphology daily with light microscopy. We test for mycoplasma on a routine basis. We can also perform qPCR arrays to detect common chromosomal aberrations found in PSCs using commercial assays. We do not offer karyotyping analysis.
Past project data:
